IoM Report To Address Colorectal Cancer Cost-Effectiveness, Surveillance
This article was originally published in The Gray Sheet
Executive Summary
Preventing a quick death from colorectal cancer diagnosed at a late stage is not cost-effective, according to Martin Brown, PhD, chief of the National Cancer Institute's Health Services & Economics Branch